Literature DB >> 12904130

Adverse effects of antiretroviral therapy: focus on orofacial effects.

Pedro Diz Dios1, Crispian Scully.   

Abstract

The optimum anti-HIV drug has yet to be found. This paper will summarise some of the oral adverse effects associated with antiretroviral agents against HIV. The development of antiretroviral drugs for the treatment of HIV infection has been aimed at the inactivation of two HIV enzymes: reverse transcriptase and proteases. Erythema multiforme, ulcers and xerostomia are the main oral side effects associated with reverse transcriptase inhibitors. Parotid lipomatosis, taste disturbance, xerostomia and perioral paraesthesia are oral adverse effects, which are mainly related to protease inhibitor therapy. The search for new antiretrovirals with different active mechanisms and patterns of resistance constitutes a key question in HIV treatment. The use of new drugs and drug combinations will lead to the appearance of oral lesions, which will be difficult to identify and treat and which cannot be ignored by the practitioner.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12904130     DOI: 10.1517/14740338.1.4.307

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  5 in total

1.  The HIV protease inhibitor lopinavir/ritonavir (Kaletra) alters the growth, differentiation and proliferation of primary gingival epithelium.

Authors:  M Israr; D Mitchell; S Alam; D Dinello; J J Kishel; C Meyers
Journal:  HIV Med       Date:  2010-08-15       Impact factor: 3.180

2.  Effect of the HIV nucleoside reverse transcriptase inhibitor zidovudine on the growth and differentiation of primary gingival epithelium.

Authors:  D Mitchell; M Israr; S Alam; J Kishel; D Dinello; C Meyers
Journal:  HIV Med       Date:  2012-01-26       Impact factor: 3.180

3.  Effect of the HIV protease inhibitor amprenavir on the growth and differentiation of primary gingival epithelium.

Authors:  Mohd Israr; Danielle Mitchell; Samina Alam; Donald Dinello; Joseph J Kishel; Craig Meyers
Journal:  Antivir Ther       Date:  2010

4.  HIV nucleoside reverse transcriptase inhibitors efavirenz and tenofovir change the growth and differentiation of primary gingival epithelium.

Authors:  D Mitchell; M Israr; S Alam; D Dinello; J Kishel; R Jia; C Meyers
Journal:  HIV Med       Date:  2013-10-31       Impact factor: 3.180

5.  The effect of antiretroviral therapy initiation on vitamin D levels and four oral diseases among Kenyan children and adolescents living with HIV.

Authors:  Ana Lucia Seminario; Arthur Kemoli; Walter Fuentes; Yan Wang; Poojashree Rajanbabu; Dalton Wamalwa; Sarah Benki-Nugent; Grace John-Stewart; Jennifer A Slyker
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.